Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

599 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dementia wellbeing and COVID-19: Review and expert consensus on current research and knowledge gaps.
Liu KY, Howard R, Banerjee S, Comas-Herrera A, Goddard J, Knapp M, Livingston G, Manthorpe J, O'Brien JT, Paterson RW, Robinson L, Rossor M, Rowe JB, Sharp DJ, Sommerlad A, Suárez-González A, Burns A. Liu KY, et al. Int J Geriatr Psychiatry. 2021 Nov;36(11):1597-1639. doi: 10.1002/gps.5567. Epub 2021 May 27. Int J Geriatr Psychiatry. 2021. PMID: 34043836 Free PMC article. Review.
Guidelines for the management of agitation in dementia.
Howard R, Ballard C, O'Brien J, Burns A; UK and Ireland Group for Optimization of Management in dementia. Howard R, et al. Int J Geriatr Psychiatry. 2001 Jul;16(7):714-7. doi: 10.1002/gps.418. Int J Geriatr Psychiatry. 2001. PMID: 11466751 No abstract available.
Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology.
Burns A, O'Brien J; BAP Dementia Consensus group; Auriacombe S, Ballard C, Broich K, Bullock R, Feldman H, Ford G, Knapp M, McCaddon A, Iliffe S, Jacova C, Jones R, Lennon S, McKeith I, Orgogozo JM, Purandare N, Richardson M, Ritchie C, Thomas A, Warner J, Wilcock G, Wilkinson D; British Association for Psychopharmacology. Burns A, et al. J Psychopharmacol. 2006 Nov;20(6):732-55. doi: 10.1177/0269881106068299. J Psychopharmacol. 2006. PMID: 17060346 Review.
Donepezil for the treatment of agitation in Alzheimer's disease.
Howard RJ, Juszczak E, Ballard CG, Bentham P, Brown RG, Bullock R, Burns AS, Holmes C, Jacoby R, Johnson T, Knapp M, Lindesay J, O'Brien JT, Wilcock G, Katona C, Jones RW, DeCesare J, Rodger M; CALM-AD Trial Group. Howard RJ, et al. N Engl J Med. 2007 Oct 4;357(14):1382-92. doi: 10.1056/NEJMoa066583. N Engl J Med. 2007. PMID: 17914039 Free article. Clinical Trial.
Vascular factors and depression.
Teper E, O'Brien JT. Teper E, et al. Int J Geriatr Psychiatry. 2008 Oct;23(10):993-1000. doi: 10.1002/gps.2020. Int J Geriatr Psychiatry. 2008. PMID: 18449953 Review.
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT.
Jones R, Sheehan B, Phillips P, Juszczak E, Adams J, Baldwin A, Ballard C, Banerjee S, Barber B, Bentham P, Brown R, Burns A, Dening T, Findlay D, Gray R, Griffin M, Holmes C, Hughes A, Jacoby R, Johnson T, Jones R, Knapp M, Lindesay J, McKeith I, McShane R, Macharouthu A, O'Brien J, Onions C, Passmore P, Raftery J, Ritchie C, Howard R; DOMINO-AD team. Jones R, et al. Trials. 2009 Jul 24;10:57. doi: 10.1186/1745-6215-10-57. Trials. 2009. PMID: 19630974 Free PMC article. Clinical Trial.
599 results